The role of tadalafil for lower urinary tract symptoms after brachytherapy
Not Applicable
- Conditions
- Prostatic cancer
- Registration Number
- JPRN-UMIN000015767
- Lead Sponsor
- Department of Urology, Shinshu University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1)Past history of urethral or prostatic surgery 2)Past history of radiation therapy for pelvic organs 3)History of severe neurogenic disorder of lower urinary tract including Parkinson disease, diabetes mellitus, etc..
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method International prostate symptom score Overactive bladder score
- Secondary Outcome Measures
Name Time Method roflowmetry (Qmax, Qave,Voided volume), residual urine, IIEF5, blood pressure, heart rate, complication (hematuria, rectal bleeding), blood test (PSA, total protein, albumin, hemoglobin, hematocrit)